Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹65.3 Cr -11.3% 0.9% -42.5% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,897.8 Cr -2.5% -3.1% 0.3% Stock Analytics
KIRI INDUSTRIES ₹2,713.6 Cr -1% -2.7% -18.4% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,548.5 Cr 0.5% -0.9% -32.4% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,024.9 Cr -0.7% -3.4% -7.7% Stock Analytics
BODAL CHEMICALS ₹590.4 Cr -0.8% -2.1% -21.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-11.3%

0.9%

-42.5%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses